142 related articles for article (PubMed ID: 8780073)
1. A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder.
Feigin A; Kurlan R; McDermott MP; Beach J; Dimitsopulos T; Brower CA; Chapieski L; Trinidad K; Como P; Jankovic J
Neurology; 1996 Apr; 46(4):965-8. PubMed ID: 8780073
[TBL] [Abstract][Full Text] [Related]
2. Deprenyl in attention deficit associated with Tourette's syndrome.
Jankovic J
Arch Neurol; 1993 Mar; 50(3):286-8. PubMed ID: 8442708
[TBL] [Abstract][Full Text] [Related]
3. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
Singer HS; Brown J; Quaskey S; Rosenberg LA; Mellits ED; Denckla MB
Pediatrics; 1995 Jan; 95(1):74-81. PubMed ID: 7770313
[TBL] [Abstract][Full Text] [Related]
4. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
[TBL] [Abstract][Full Text] [Related]
5. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
[TBL] [Abstract][Full Text] [Related]
6. A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome.
Kurlan R; Crespi G; Coffey B; Mueller-Vahl K; Koval S; Wunderlich G;
Mov Disord; 2012 May; 27(6):775-8. PubMed ID: 22407510
[TBL] [Abstract][Full Text] [Related]
7. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
[TBL] [Abstract][Full Text] [Related]
8. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study.
Cubo E; Fernández Jaén A; Moreno C; Anaya B; González M; Kompoliti K
Clin Ther; 2008 Jan; 30(1):182-9. PubMed ID: 18343255
[TBL] [Abstract][Full Text] [Related]
9. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose.
Castellanos FX; Giedd JN; Elia J; Marsh WL; Ritchie GF; Hamburger SD; Rapoport JL
J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):589-96. PubMed ID: 9136492
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder.
Gabbay V; Babb JS; Klein RG; Panzer AM; Katz Y; Alonso CM; Petkova E; Wang J; Coffey BJ
Pediatrics; 2012 Jun; 129(6):e1493-500. PubMed ID: 22585765
[TBL] [Abstract][Full Text] [Related]
11. Testing tic suppression: comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit/hyperactivity disorder and Tourette's disorder.
Lyon GJ; Samar SM; Conelea C; Trujillo MR; Lipinski CM; Bauer CC; Brandt BC; Kemp JJ; Lawrence ZE; Howard J; Castellanos FX; Woods D; Coffey BJ
J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):283-9. PubMed ID: 20807066
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette's syndrome.
Sverd J; Gadow KD; Paolicelli LM
J Am Acad Child Adolesc Psychiatry; 1989 Jul; 28(4):574-9; discussion 580-2. PubMed ID: 2768152
[TBL] [Abstract][Full Text] [Related]
13. Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome.
Spencer T; Biederman J; Steingard R; Wilens T
J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):211-4. PubMed ID: 8428875
[TBL] [Abstract][Full Text] [Related]
14. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Otasowie J; Castells X; Ehimare UP; Smith CH
Cochrane Database Syst Rev; 2014 Sep; (9):CD006997. PubMed ID: 25238582
[TBL] [Abstract][Full Text] [Related]
15. Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial.
Gilbert DL; Sethuraman G; Sine L; Peters S; Sallee FR
Neurology; 2000 Mar; 54(6):1310-5. PubMed ID: 10746603
[TBL] [Abstract][Full Text] [Related]
16. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial.
Singer HS; Wendlandt J; Krieger M; Giuliano J
Neurology; 2001 Mar; 56(5):599-604. PubMed ID: 11245709
[TBL] [Abstract][Full Text] [Related]
17. Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
Spencer T; Biederman J; Kerman K; Steingard R; Wilens T
J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):354-60. PubMed ID: 8444765
[TBL] [Abstract][Full Text] [Related]
18. Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
Spencer T; Biederman J; Wilens T; Steingard R; Geist D
J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):205-10. PubMed ID: 8428873
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
Cui YH; Zheng Y; Yang YP; Liu J; Li J
J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
[TBL] [Abstract][Full Text] [Related]
20. Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents.
Sallee F; Kohegyi E; Zhao J; McQuade R; Cox K; Sanchez R; van Beek A; Nyilas M; Carson W; Kurlan R
J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):771-781. PubMed ID: 28686474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
